milrinone has been researched along with nimodipine in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.56) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (27.78) | 29.6817 |
| 2010's | 8 (44.44) | 24.3611 |
| 2020's | 4 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Alousi, AA; Evans, DB; Grant, AM; Harris, AL; Silver, PJ | 1 |
| Anand, S; Goel, G; Gupta, V | 1 |
| Afshari, FT; Fernandes, HM; Fitzgerald, JJ; Garnett, MR; Higgins, JN; Santarius, T | 1 |
| Chowdhury, T; Schaller, B | 1 |
| Karaic, R; Kleinpeter, G; Krafft, P; Loyoddin, M; Sherif, C; Tscholakoff, D; Valentin, A; Wambacher, B | 1 |
| Dogan, R; Duman, E; Fırat, A; Karakoç, F; Pinar, HU; Yıldırım, E | 1 |
| Biais, M; Carrie, C; Cottenceau, V; Gariel, F; Petit, L; Poutier, B; Sauvage, N | 1 |
| Hawkes, MA; Hlavnicka, AA; Wainsztein, NA | 1 |
| Andereggen, L; Berberat, J; Ensner, R; Marbacher, S; Remonda, L; Steiger, HJ | 1 |
| Chakrabarti, D; Konar, SK; Kotwal, A; Radhakrishnan, M; Ramalingaiah, AH; Shukla, D; Srinivasaiah, B; Sundaram, M | 1 |
| Bäzner, H; Bhogal, P; Cimpoca, A; Ganslandt, O; Henkes, H; Khanafer, A | 1 |
1 review(s) available for milrinone and nimodipine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
17 other study(ies) available for milrinone and nimodipine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Differential vasorelaxant effects of milrinone and amrinone on contractile responses of canine coronary, cerebral, and renal arteries.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Amrinone; Animals; Cerebral Arteries; Coronary Vessels; Dinoprost; Dogs; Female; In Vitro Techniques; Isoproterenol; Male; Milrinone; Muscle Relaxation; Muscle, Smooth, Vascular; Nimodipine; Potassium; Prostaglandin Endoperoxides, Synthetic; Pyridones; Renal Artery; Sodium Nitrite | 1989 |
Continuous intra-arterial dilatation with nimodipine and milrinone for refractory cerebral vasospasm.
Topics: Angioplasty, Balloon; Cerebral Angiography; Dilatation; Drug Resistance; Female; Humans; Infusions, Intravenous; Middle Aged; Milrinone; Nervous System Diseases; Nimodipine; Subarachnoid Hemorrhage; Vasodilator Agents; Vasospasm, Intracranial | 2014 |
Diffuse cerebral vasospasm following resection of a hypoglossal schwannoma in a child.
Topics: Cerebral Angiography; Child; Cranial Nerve Neoplasms; Female; Humans; Milrinone; Neurilemmoma; Nimodipine; Postoperative Complications; Vasospasm, Intracranial | 2014 |
The need for development of protocol for managing refractory cerebral vasospasm.
Topics: Female; Humans; Milrinone; Nimodipine; Vasodilator Agents; Vasospasm, Intracranial | 2014 |
Repeated combined endovascular therapy with milrinone and nimodipine for the treatment of severe vasospasm: preliminary results.
Topics: Adult; Combined Modality Therapy; Endovascular Procedures; Female; Follow-Up Studies; Humans; Male; Milrinone; Nimodipine; Pilot Projects; Retrospective Studies; Severity of Illness Index; Subarachnoid Hemorrhage; Treatment Outcome; Ultrasonography, Doppler, Transcranial; Vasodilator Agents; Vasospasm, Intracranial | 2015 |
Higher dose intra-arterial milrinone and intra-arterial combined milrinone-nimodipine infusion as a rescue therapy for refractory cerebral vasospasm.
Topics: Angiography, Digital Subtraction; Cerebral Angiography; Computed Tomography Angiography; Drug Therapy, Combination; Female; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Milrinone; Nimodipine; Retrospective Studies; Subarachnoid Hemorrhage; Treatment Outcome; Vasodilator Agents; Vasospasm, Intracranial | 2017 |
May levosimendan be safe and effective in refractory vasospasm despite adequate treatment with repeated angiography and milrinone infusion after subarachnoid haemorrhage?
Topics: Aneurysm, Ruptured; Cardiotonic Agents; Cerebral Angiography; Cerebrospinal Fluid Leak; Computed Tomography Angiography; Drug Resistance; Drug Substitution; Drug Therapy, Combination; Embolization, Therapeutic; Humans; Infusions, Intravenous; Intracranial Aneurysm; Intracranial Pressure; Magnesium Sulfate; Male; Middle Aged; Milrinone; Nimodipine; Simendan; Subarachnoid Hemorrhage; Vasospasm, Intracranial; Ventricular Dysfunction, Left | 2019 |
Reversible Cerebral Vasoconstriction Syndrome Responsive to Intravenous Milrinone.
Topics: Adult; Angiography, Digital Subtraction; Aphasia, Broca; Brain Edema; Cerebral Hemorrhage; Computed Tomography Angiography; Decompressive Craniectomy; Disease Progression; Drainage; Female; Humans; Hydrocephalus; Hyperemia; Middle Cerebral Artery; Milrinone; Nimodipine; Paresis; Puerperal Disorders; Severity of Illness Index; Treatment Outcome; Ultrasonography, Doppler, Transcranial; Vasodilator Agents; Vasospasm, Intracranial; Ventriculostomy | 2020 |
Hemodynamic response and clinical outcome following intravenous milrinone plus norepinephrine-based hyperdynamic hypertensive therapy in patients suffering secondary cerebral ischemia after aneurysmal subarachnoid hemorrhage.
Topics: Brain Ischemia; Cerebral Infarction; Hemodynamics; Humans; Hypertension; Milrinone; Nimodipine; Norepinephrine; Subarachnoid Hemorrhage; Vasodilator Agents; Vasospasm, Intracranial | 2022 |
Role of Nimodipine and Milrinone in Delayed Cerebral Ischemia.
Topics: Brain Ischemia; Cerebral Infarction; Humans; Milrinone; Nimodipine; Subarachnoid Hemorrhage; Vasospasm, Intracranial | 2022 |
Intracranial stenting as a bail-out option for posthemorrhagic cerebral vasospasm: a single-center experience with long-term follow-up.
Topics: Aortic Aneurysm, Abdominal; Blood Vessel Prosthesis Implantation; Endovascular Procedures; Eptifibatide; Follow-Up Studies; Humans; Milrinone; Nimodipine; Platelet Aggregation Inhibitors; Retrospective Studies; Stents; Vasospasm, Intracranial | 2022 |